Skip to main content

Boston Scientific buys Harker School grad's med-tech business for $275M

San Bruno-based nVision makes a microcatheter device used to screen for ovarian cancer and was founded by a 32-year-old female CEO who was honored last year as a distinguished alumnus of the Harker School in San Jose. She had raised only $17 million in venture funding before the sale.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.